Kim DH, Vaccaro AR. Osteoporotic compression fractures of the spine: current options and considerations for treatment. Spine J. 2006;6:479-487.
McAfee PC, Yuan HA, Fredrickson BE, et al. The value of computed tomography in thoracolumbar fractures: An analysis of one hundred cases and a new classification. J Bone Joint Surg. 1983;65:461-473.
Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organization technical report series. Osteoporosis Int. 1994;843:1-129.
Iqbal MM, Sobhan T. Osteoporosis: a review. Mo Med. 2002;99:19-24.
Gold DT. The clinical impact of vertebral fractures: Quality of life in women with osteoporosis. Bone. 1996;18(suppl 3):185S-189S.
Anderson PA, Froyshteter AB, Tontz WL Jr. Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. J Bone Miner Res. 2013;28:372-382.
Lee MJ, Dumonski M, Cahill P, et al. Percutaneous treatment of vertebral compression fractures: a meta-analysis of complications. Spine (Phila Pa 1976). 2009;34:1228-1232.
Taylor RS, Fritzell P, Taylor RJ. Balloon kyphoplasty in the management of vertebral compression fractures: an updated systematic review and meta-analysis. Eur Spine J. 2007;16:1085-1100.
Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009;373:1016-1024.
Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361:569-579.
Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557-568.
Muijs SP, van Erkel AR, Dijkstra PD. Treatment of painful osteoporotic vertebral compression fractures: a brief review of the evidence for percutaneous vertebroplasty. J Bone Joint Surg Br. 2011;93:1149-1153.
Lippuner K. Medical treatment of vertebral osteoporosis. Eur Spine J. 2003:12 (Suppl 2):S132-S141.
1. Kim DH, Vaccaro AR. Osteoporotic compression fractures of the spine: current options and considerations for treatment. Spine J. 2006;6:479-487.
2. Denis F. The three-column spine and its significance in the classification of acute thoracolumbar spinal injuries. Spine (Phila Pa 1976). 1983;8:817-831.
3. Sugita M, Watanabe N, Mikami Y, et al. Classification of vertebral compression fractures in the osteoporotic spine. J Spinal Disord Tech. 2005;18:376-381.
4. Wu CT, Lee SC, Lee ST, et al. Classification of symptomatic osteoporotic compression fractures of the thoracic and lumbar spine. J Clin Neuroscience. 2006;13:1-38.
5. McAfee PC, Yuan HA, Fredrickson BE, et al. The value of computed tomography in thoracolumbar fractures: An analysis of one hundred cases and a new classification. J Bone Joint Surg. 1983;65:461-473.
6. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organization technical report series. Osteoporosis Int. 1994;843:1-129.
7. Tarantino U, Cannata G, Lecce D, et al. Incidence of fragility fractures. Aging Clin Exp Res. 2007;19(4 Suppl):7-11.
8. America's bone health: the state of osteoporosis and low bone mass in our nation. Washington, DC: National Osteoporosis Foundation; 2002.
9. Johnell O. Advances in osteoporosis: Better identification of risk factors can reduce morbidity and mortality. J Intern Med. 1996;239:299-304.
10. Iqbal MM, Sobhan T. Osteoporosis: a review. Mo Med. 2002;99:19-24.
11. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22:465-475.
12. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726-1733.
13. Gold DT. The clinical impact of vertebral fractures: Quality of life in women with osteoporosis. Bone. 1996;18(suppl 3):185S-189S.
14. Silverman SL. The clinical consequences of vertebral compression fracture. Bone. 1992;13(suppl 2):27S-31S.
15. Lane JM, Nydick M. Osteoporosis: current modes of prevention and treatment, J Am Acad Orthop Surg. 1999;7:19-31.
16. Ross PD, Davis JW, Epstein RS, et al. Pre-existing fractures and bone mass may predict vertebral fracture incidence in women. Ann Intern Med. 1991;114:919-923.
17. Gunnes M, Lehmann EH, Mellstrom D, et al. The relationship between anthropometric measurements and fractures in women. Bone. 1996;19:407-413.
18. Riggs BL, Melton LJ 3rd. Involutional osteoporosis. N Engl J Med. 1986;314:1676-1686.
19. Burger H, de Laet CE, van Daele PL, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiology. 1998;147:871-879.
20. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315:841-846.
21. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-795.
22. WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and management of osteoporosis: report of a WHO scientific group. WHO technical report series no. 921. Geneva, Switzerland; 2003.
23. Dennison E, Eastell R, Fall CH, et al. Determinants of bone loss in elderly men and women: a prospective study. Osteoporosis Int. 1999;10:384-391.
24. Mazziotti G, Angeli A, Bilezikian JP, et al. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab. 2006;17:144-149.
25. Lakatos P. Thyroid hormones: beneficial or deleterious for bone? Calcif Tissue Int. 2003;73:205-209.
26. Jackson RD, LaCroix AZ, Gass M. Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669-683.
27. Nakchbandi IA, van der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:660-670.
28. National Institute for Health and Care Excellence. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. January 2011. http://www.nice.org.uk/ (last accessed 22 March 2017).
29. National Institute for Health and Care Excellence. Denosumab for the prevention of osteoporotic fractures in postmenopausal women. October 2010. http://www.nice.org.uk (last accessed 22 March 2017).
30. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. 2014. http://www.nof.org (last accessed 22 March 2017).
31. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen (CEE) in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701-1712.
32. European Medicines Agency. European Medicines Agency recommends limiting long-term use of calcitonin medicines. July 2012. http://www.ema.europa.eu/ (last accessed 22 March 2017).
33. US Preventive Services Task Force. Screening for osteoporosis: US preventive services task force recommendation statement. Ann Intern Med. 2011;154:356-364.
34. Schmitz A, Risse JH, Textor J, et al. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporosis Int. 2002;13:755-761.
35. Faciszewski T, Kiernan F, Rao R. Treatment of osteoporotic vertebral compression fractures. In: Spivak JM, Connolly PJ, eds. Orthopedic knowledge update, Spine 3. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2006.
36. Rupp RE, Ebraheim NA, Coombs RJ. Magnetic resonance imaging differentiation of compression spine fractures or vertebral lesions caused by osteoporosis or tumor. Spine. 1995;20:2499-2504.
37. Herkowitz HN, Garfin SR, Eismont FJ, et al. Rothman-Simeone: the spine, volume 2. Philadelphia, PA: Saunders-Elsevier; 2006:1408-1409.
38. Anderson PA, Froyshteter AB, Tontz WL Jr. Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. J Bone Miner Res. 2013;28:372-382.
39. Mattie R, Laimi K, Yu S, et al. Comparing percutaneous vertebroplasty and conservative therapy for treating osteoporotic compression fractures in the thoracic and lumbar spine: a systematic review and meta-analysis. J Bone Joint Surg Am. 2016;98:1041-1051.
40. Felder-Puig R, Piso B, Guba B, et al. Kyphoplasty and vertebroplasty for the management of osteoporotic vertebral compression fractures: a systematic review [in German]. Orthopade. 2009;38:606-615.
41. Lee MJ, Dumonski M, Cahill P, et al. Percutaneous treatment of vertebral compression fractures: a meta-analysis of complications. Spine (Phila Pa 1976). 2009;34:1228-1232.
42. Taylor RS, Fritzell P, Taylor RJ. Balloon kyphoplasty in the management of vertebral compression fractures: an updated systematic review and meta-analysis. Eur Spine J. 2007;16:1085-1100.
43. Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009;373:1016-1024.
44. Ström O, Leonard C, Marsh D, et al. Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting. Osteoporos Int. 2010;21:1599-1608.
45. Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361:569-579.
46. Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557-568.
47. Muijs SP, van Erkel AR, Dijkstra PD. Treatment of painful osteoporotic vertebral compression fractures: a brief review of the evidence for percutaneous vertebroplasty. J Bone Joint Surg Br. 2011;93:1149-1153.
48. Ma XL, Xing D, Ma JX, et al. Balloon kyphoplasty versus percutaneous vertebroplasty in treating osteoporotic vertebral compression fracture: grading the evidence through a systematic review and meta-analysis. Eur Spine J. 2012;21:1844-1859.
49. National Institute for Health and Care Excellence. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures. April 2013. http://guidance.nice.org.uk/TA279 (last accessed 22 March 2017).
50. Lippuner K. Medical treatment of vertebral osteoporosis. Eur Spine J. 2003:12 (Suppl 2):S132-S141.
51. National Institute for Health and Care Excellence. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. January 2011. http://www.nice.org.uk/ (last accessed 22 March 2017).
52. Lyles KW, Gold DT, Shipp KM, et al. Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med. 1993;94:595-601.
53. Choe DH, Marom EM, Ahrar K, et al. Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty. AJR Am J Roentgenol. 2004;183:1097-1102.
54. Watts NB, Harris ST, Genant HK. Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty. Osteoporos Int. 2001;12:429-437.
55. Giangregorio LM, Macintyre NJ, Thabane L, et al. Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev. 2013;(1):CD008618.
56. Lyles KW. Management of patients with vertebral compression fractures. Pharmacotherapy. 1999;19(1 pt 2):21S-24S.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台